Myristoylation-dependent membrane targeting and release of the HTLV-I Gag precursor, Pr53gag, in yeast

Area of Science:

• Molecular Biology
• Virology
• Yeast Genetics

Background:

• The human T-lymphotropic virus type I (HTLV-I) is a retrovirus implicated in various diseases.
• Understanding the early stages of viral protein processing, such as the Gag precursor, is crucial for developing therapeutic strategies.
• The yeast Saccharomyces cerevisiae offers a powerful system for studying eukaryotic protein expression and modification.

Purpose of the Study:

• To investigate the synthesis and post-translational modification of the unprocessed HTLV-I Gag precursor (Pr53gag) in yeast.
• To determine the role of myristoylation in the cellular association and release of Pr53gag.
• To explore the potential of yeast as a model system for studying HTLV-I Pr53gag processing.

Main Methods:

• Synthesis of unprocessed HTLV-I Pr53gag in Saccharomyces cerevisiae.
• Analysis of Pr53gag myristoylation and cellular membrane association.
• Investigation of Pr53gag release into the culture medium using high-speed centrifugation.
• Site-directed mutagenesis to create a non-myristoylated Pr53gag mutant (Gly2 to Ala conversion).

Main Results:

• Synthesized Pr53gag in yeast was successfully myristoylated and associated with the cellular membrane.
• Myristoylated Pr53gag was released into the culture medium.
• A non-myristoylated Pr53gag mutant (Gly2Ala) remained soluble and was not released.
• These findings demonstrate myristoylation-dependent release of HTLV-I Pr53gag in yeast.

Conclusions:

• Myristoylation is a critical determinant for the release of HTLV-I Pr53gag from yeast cells.
• Yeast can serve as a viable system for studying the myristoylation-dependent processing of retroviral Gag precursors.
• This study provides insights into the early events of HTLV-I assembly and maturation.